NecstGen provides contract development, manufacturing and rental services to academic/small industrial therapy developers to deliver new therapies to patients.
NecstGen will attend Oxford Global Conferences Cell UK conference on October 28 & 29. NecstGen’s Head of Cell Therapy, Melissa Van Pel, will discuss the challenges and routes to success for Cell and...
Interested in ATMP development and its challenges? Join us at the Leiden Bio Science Park TechTalks! 💉 Have a look at the program and see you there? 👇 Starting with and from the Leiden Biosciences...
Welcome Jeroen! We are pleased with the addition of Jeroen Meerding to our Viral Vector team. Check out our career page at: https://necstgen.com/ | 20 comments on LinkedIn
ALT NecstGen launches its first development laboratory at the Leiden Bio Science Park.